Sign in
4

Changes in Ownership

Design Therapeutics, Inc. Filed Acc 0001883722-26-000002

Options or other derivatives

  • Chief Accounting Officer acquired 150,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Burgess Julie · Chief Accounting Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-01-02 Grant or award : show line 1 in the form Stock option (right to buy) +150,000 150,000 D
Loading xslF345X05/form4-01052026_090130.xml…